NCT03288259

Brief Summary

Transnasal Endoscopy in Obese Patients are Candidates for Bariatric Surgery Introduction and Objectives: high digestive endoscopy (HDE) is an important tool in the preoperative period of bariatric surgery. Patients with excess weight have a higher risk of cardiorespiratory complications during this procedure, being that the transnasal endoscopy (TNE) with an endoscope-thin is a safe alternative, comfortable and great value for money. The TNE allows the study of the upper gastrointestinal tract without the need for sedation. The objective of this work was to evaluate the feasibility, tolerance and safety of TNE in obese patients are candidates for bariatric surgery. Methods: This was a prospective study with all patients with indication for surgery of obesity undergoing endoscopic transnasal preoperatively, between December 2016 and August 2018, at the Hospital of the Federal University of Minas Gerais. The variables evaluated were: age, gender, suitability of the exam, tolerance by the patient through the visual analogue scale, incidence of complications and need for sedation. Oxygen saturation, heart rate and systolic blood pressure were recorded. Conclusion: The transnasal endoscopy is a feasible alternative, well tolerated and safe the conventional endoscopy in evolution the preoperative bariatric surgery. The benefits of transnasal endoscopy in obese patients mainly consist in carrying out the procedure without sedation, which may provide reduction of risks, costs and waive the need for a companion. Key words: transnasal endoscopy - Obesity - endoscopy without sedation.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
100

participants targeted

Target at P50-P75 for not_applicable obesity

Timeline
Completed

Started Dec 2016

Typical duration for not_applicable obesity

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2016

Completed
8 months until next milestone

First Submitted

Initial submission to the registry

August 2, 2017

Completed
2 months until next milestone

First Posted

Study publicly available on registry

September 20, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 1, 2019

Completed
2 months until next milestone

Study Completion

Last participant's last visit for all outcomes

May 1, 2019

Completed
Last Updated

February 15, 2019

Status Verified

February 1, 2019

Enrollment Period

2.2 years

First QC Date

August 2, 2017

Last Update Submit

February 13, 2019

Conditions

Keywords

Transnasal endoscopy - Obesity - endoscopy without sedation

Outcome Measures

Primary Outcomes (1)

  • Feasibility of the procedure

    The exam will be considered feasible if the appliance reaches the second duodenal portion and is performed retroflexão, allowing the visualization of all portions of the digestive system and the achievement of biopsies if necessary. All patients will complete a questionnaire 15 to 30 minutes after the transnasal endoscopy and will be released next to the house. All of this information and the results will be compared with the main data in the literature. Bivariate analyzes shall be calculated from the test "t" test for continuous variables and the chi-square test or Fisher exact test for categorical variables. Proportions will be reported by categorical data; and mean, median and standard deviation for continuous variables. P values less than 0.05 are considered statistically significant.

    15 minutes

Study Arms (1)

Obese patients

EXPERIMENTAL

Obese patients undergoing Local Anesthetics and Transnasal Endoscopy.

Procedure: transnasal endoscopyDrug: Local Anesthetics,Topical

Interventions

Transnasal endoscopy without sedation with ultra-thin endoscopes in patients who are candidates for bariatric surgery

Obese patients

Will be carried out topical anesthesia of the pharynx with lidocaine spray (10%) 6 puffs and instillation of nasal vasoconstrictor 4 drops.

Obese patients

Eligibility Criteria

Age18 Years - 65 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • A BMI greater than or equal to 40 Kg/m²
  • A BMI greater or equal 35 Kg/m² associated with comorbidity (e.g., arterial hypertension, diabetes, dyslipidemia, sleep apnea)

You may not qualify if:

  • Surgery, fractures or nasal malformations
  • History of epistaxis
  • Allergy to components of the topical anesthetic used prior to the examination
  • Coagulation disorders or use of anticoagulants
  • Pregnancy
  • Psychiatric disorder important

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Alpha Institute of Gastroenterology - HC/UFMG Rua Alfredo Balena, 110 - 2. Cycling - Santa Efigênia.

Belo Horizonte, Minas Gerais, 30130100, Brazil

RECRUITING

MeSH Terms

Conditions

Obesity

Interventions

Anesthetics, Local

Condition Hierarchy (Ancestors)

OverweightOvernutritionNutrition DisordersNutritional and Metabolic DiseasesBody WeightSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

AnestheticsCentral Nervous System DepressantsPhysiological Effects of DrugsPharmacologic ActionsChemical Actions and UsesSensory System AgentsPeripheral Nervous System AgentsCentral Nervous System AgentsTherapeutic Uses

Central Study Contacts

Study Design

Study Type
interventional
Phase
not applicable
Allocation
NA
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
SINGLE GROUP
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Principal Investigator

Study Record Dates

First Submitted

August 2, 2017

First Posted

September 20, 2017

Study Start

December 1, 2016

Primary Completion

March 1, 2019

Study Completion

May 1, 2019

Last Updated

February 15, 2019

Record last verified: 2019-02

Data Sharing

IPD Sharing
Will not share

Participants can be identified by the number of medical records and phone contacts have been duly authorized by the institution responsible.

Locations